Metraipolis › archive › dc_c024e7df4f36

Evaluation of aflibercept treatment outcomes using optical coherence tomography angiography in macular telangiectasia type 1 — Europe PMC PMID:41578203

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41578203
DOI
10.1186/s12886-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-11-06T13:00:24.727Z
SHA-256 of the archived text
ae367ccc0d136c72f5f68072f576910b9bc969904f5ec39e15532d300c2be3ff
Stable URL of this page
https://metraipolis.com/documento/dc_c024e7df4f36

How to cite

Evaluation of aflibercept treatment outcomes using optical coherence tomography angiography in macular telangiectasia type 1 — Europe PMC PMID:41578203 — Europe PMC (en), https://europepmc.org/article/MED/41578203 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c024e7df4f36 (Metraipolis archive dc_c024e7df4f36, sha256 ae367ccc0d136c72f5f68072f576910b9bc969904f5ec39e15532d300c2be3ff)
BibTeX
@misc{dcc024e7df4f36,
  title = {Evaluation of aflibercept treatment outcomes using optical coherence tomography angiography in macular telangiectasia type 1 — Europe PMC PMID:41578203},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41578203},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c024e7df4f36; sha256 ae367ccc0d136c72f5f68072f576910b9bc969904f5ec39e15532d300c2be3ff},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41578203. Agents can read the archived copy with the MCP tool read_document.